Search details
1.
Exagamglogene Autotemcel for Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 390(18): 1663-1676, 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38657265
2.
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
N Engl J Med
; 390(18): 1649-1662, 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38661449
3.
Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.
N Engl J Med
; 386(24): 2295-2302, 2022 06 16.
Article
in English
| MEDLINE | ID: mdl-35704481
4.
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Blood
; 142(24): 2105-2118, 2023 12 14.
Article
in English
| MEDLINE | ID: mdl-37562003
5.
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
J Allergy Clin Immunol
; 153(1): 287-296, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37793572
6.
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
Clin Immunol
; 261: 109942, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38367737
7.
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet
; 402(10396): 129-140, 2023 07 08.
Article
in English
| MEDLINE | ID: mdl-37352885
8.
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
N Engl J Med
; 384(21): 2002-2013, 2021 05 27.
Article
in English
| MEDLINE | ID: mdl-33974366
9.
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Blood
; 140(7): 685-705, 2022 08 18.
Article
in English
| MEDLINE | ID: mdl-35671392
10.
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
J Allergy Clin Immunol
; 151(2): 539-546, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36456361
11.
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
J Allergy Clin Immunol
; 151(2): 547-555.e5, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36456360
12.
Viral-specific T cells for Cytomegalovirus retinitis following hematopoietic stem cell transplantation: A success story.
Pediatr Blood Cancer
; 70(8): e30429, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37243390
13.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood
; 135(23): 2094-2105, 2020 06 04.
Article
in English
| MEDLINE | ID: mdl-32268350
14.
Diaphragmatic Thickening Fraction by Ultrasound in Mechanically Ventilated Pediatric Patients: Pilot Observations During Spontaneous Breathing Trials.
J Ultrasound Med
; 41(12): 3043-3050, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35670278
15.
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
J Clin Immunol
; 41(1): 38-50, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33006109
16.
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 40(8): 1211-1213, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32860171
17.
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
N Engl J Med
; 386(26): 2538-2539, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35767453
18.
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
N Engl J Med
; 377(17): 1630-1638, 2017 10 26.
Article
in English
| MEDLINE | ID: mdl-28976817
19.
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 362-368, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30287390
20.
Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
J Clin Immunol
; 39(8): 786-794, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31620947